Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 63

    1.

    Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome.

    Kawai T, Ng MC, Hayes MG, Yoshiuchi I, Tsuchiya T, Robertson H, Cox NJ, Polonsky KS, Bell GI, Ehrmann DA.

    Diabetes Res Clin Pract. 2009 Dec;86(3):186-92. Epub 2009 Sep 25.PMID: 19782423 [PubMed - in process]Related articles

    2.

    Polycystic Ovary Syndrome and Obstructive Sleep Apnea.

    Tasali E, Van Cauter E, Ehrmann DA.

    Sleep Med Clin. 2008 Mar;3(1):37-46.PMID: 19255602 [PubMed]Related articlesFree article

    3.

    Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.

    Mortensen M, Ehrmann DA, Littlejohn E, Rosenfield RL.

    J Clin Endocrinol Metab. 2009 May;94(5):1579-86. Epub 2009 Feb 24.PMID: 19240158 [PubMed - indexed for MEDLINE]Related articles

    4.

    Characterization of functionally typical and atypical types of polycystic ovary syndrome.

    Hirshfeld-Cytron J, Barnes RB, Ehrmann DA, Caruso A, Mortensen MM, Rosenfield RL.

    J Clin Endocrinol Metab. 2009 May;94(5):1587-94. Epub 2009 Feb 24.PMID: 19240152 [PubMed - indexed for MEDLINE]Related articles

    5.

    The vital role of ORWH.

    Hultgren S, Goldstein JM, Delancey JO, Bandstra ES, Brady KT, Brown JS, Deng HW, Dunaif A, Ehrmann DA, Mayer EA, Sinha R, Tobet S, Levine JE.

    Science. 2009 Feb 20;323(5917):1009-10. No abstract available. PMID: 19229019 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome.

    Tasali E, Van Cauter E, Hoffman L, Ehrmann DA.

    J Clin Endocrinol Metab. 2008 Oct;93(10):3878-84. Epub 2008 Jul 22.PMID: 18647805 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

    Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, Shapiro J, Montori VM, Swiglo BA.

    J Clin Endocrinol Metab. 2008 Apr;93(4):1105-20. Epub 2008 Feb 5. Review.PMID: 18252793 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cardiometabolic features of polycystic ovary syndrome.

    Hoffman LK, Ehrmann DA.

    Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):215-22. Epub 2008 Feb 5. Review.PMID: 18250636 [PubMed - indexed for MEDLINE]Related articles

    9.

    Slow-wave sleep and the risk of type 2 diabetes in humans.

    Tasali E, Leproult R, Ehrmann DA, Van Cauter E.

    Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1044-9. Epub 2008 Jan 2.PMID: 18172212 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program.

    Lachin JM, Christophi CA, Edelstein SL, Ehrmann DA, Hamman RF, Kahn SE, Knowler WC, Nathan DM; DDK Research Group.

    Diabetes. 2007 Apr;56(4):1153-9.PMID: 17395752 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Pharmacologic therapy of polycystic ovary syndrome.

    Dronavalli S, Ehrmann DA.

    Clin Obstet Gynecol. 2007 Mar;50(1):244-54.PMID: 17304039 [PubMed - indexed for MEDLINE]Related articles

    12.

    Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome.

    Qin K, Ehrmann DA, Cox N, Refetoff S, Rosenfield RL.

    J Clin Endocrinol Metab. 2006 Jan;91(1):270-6. Epub 2005 Nov 1. Erratum in: J Clin Endocrinol Metab. 2006 Feb;91(2):529. PMID: 16263811 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.

    Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN; PCOS/Troglitazone Study Group.

    J Clin Endocrinol Metab. 2006 Jan;91(1):48-53. Epub 2005 Oct 25.PMID: 16249284 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.

    Tasali E, Van Cauter E, Ehrmann DA.

    J Clin Endocrinol Metab. 2006 Jan;91(1):36-42. Epub 2005 Oct 11.PMID: 16219719 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.

    Knowler WC, Hamman RF, Edelstein SL, Barrett-Connor E, Ehrmann DA, Walker EA, Fowler SE, Nathan DM, Kahn SE; Diabetes Prevention Program Research Group.

    Diabetes. 2005 Apr;54(4):1150-6.PMID: 15793255 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Polycystic ovary syndrome.

    Ehrmann DA.

    N Engl J Med. 2005 Mar 24;352(12):1223-36. Review. No abstract available. PMID: 15788499 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.

    Ehrmann DA, Kasza K, Azziz R, Legro RS, Ghazzi MN; PCOS/Troglitazone Study Group.

    J Clin Endocrinol Metab. 2005 Jan;90(1):66-71. Epub 2004 Oct 26.PMID: 15507516 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Genetic contributions to glucose intolerance in polycystic ovary syndrome.

    Ehrmann DA.

    Reprod Biomed Online. 2004 Jul;9(1):28-34.PMID: 15257813 [PubMed - indexed for MEDLINE]Related articles

    19.

    Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls.

    Weiner CL, Primeau M, Ehrmann DA.

    Psychosom Med. 2004 May-Jun;66(3):356-62.PMID: 15184695 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Association of the (AU)AT-rich element polymorphism in PPP1R3 with hormonal and metabolic features of polycystic ovary syndrome.

    Alcoser SY, Hara M, Bell GI, Ehrmann DA.

    J Clin Endocrinol Metab. 2004 Jun;89(6):2973-6.PMID: 15181086 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.

    Rosenfield RL, Barnes RB, Ehrmann DA, Toledano AY.

    J Clin Endocrinol Metab. 2003 Dec;88(12):6115; author reply 6115-6. No abstract available. PMID: 14671222 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome.

    Ehrmann DA, Breda E, Corcoran MC, Cavaghan MK, Imperial J, Toffolo G, Cobelli C, Polonsky KS.

    Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E241-6. Epub 2003 Dec 9.PMID: 14665448 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Pharmacologic treatment of polycystic ovary syndrome.

    Ehrmann DA, Rychlik D.

    Semin Reprod Med. 2003 Aug;21(3):277-83. Review.PMID: 14593550 [PubMed - indexed for MEDLINE]Related articles

    24.

    Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.

    Azziz R, Ehrmann DA, Legro RS, Fereshetian AG, O'Keefe M, Ghazzi MN; PCOS/Troglitazone Study Group.

    Fertil Steril. 2003 Apr;79(4):932-7.PMID: 12749433 [PubMed - indexed for MEDLINE]Related articles

    25.

    Insulin resistance and polycystic ovary syndrome.

    Ehrmann DA.

    Curr Diab Rep. 2002 Feb;2(1):71-6. Review.PMID: 12643125 [PubMed - indexed for MEDLINE]Related articles

    26.

    Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.

    Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ, Bell GI.

    J Clin Endocrinol Metab. 2002 Sep;87(9):4297-300.PMID: 12213887 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.

    Ehrmann DA, Breda E, Cavaghan MK, Bajramovic S, Imperial J, Toffolo G, Cobelli C, Polonsky KS.

    Diabetologia. 2002 Apr;45(4):509-17.PMID: 12032626 [PubMed - indexed for MEDLINE]Related articles

    28.

    Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.

    Ehrmann DA, Schwarz PE, Hara M, Tang X, Horikawa Y, Imperial J, Bell GI, Cox NJ.

    J Clin Endocrinol Metab. 2002 Apr;87(4):1669-73.PMID: 11932299 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene.

    Hara M, Alcoser SY, Qaadir A, Beiswenger KK, Cox NJ, Ehrmann DA.

    J Clin Endocrinol Metab. 2002 Feb;87(2):772-5.PMID: 11836319 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives.

    Colilla S, Cox NJ, Ehrmann DA.

    J Clin Endocrinol Metab. 2001 May;86(5):2027-31.PMID: 11344202 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models.

    Toffolo G, Breda E, Cavaghan MK, Ehrmann DA, Polonsky KS, Cobelli C.

    Am J Physiol Endocrinol Metab. 2001 Jan;280(1):E2-10.PMID: 11120653 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Glucose intolerance in the polycystic ovary syndrome: role of the pancreatic beta-cell.

    Ehrmann DA.

    J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1299-301. Review.PMID: 11117674 [PubMed - indexed for MEDLINE]Related articles

    33.

    Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism.

    Rosenfield RL, Ghai K, Ehrmann DA, Barnes RB.

    J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1285-9.PMID: 11117671 [PubMed - indexed for MEDLINE]Related articles

    34.

    Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.

    Cavaghan MK, Ehrmann DA, Polonsky KS.

    J Clin Invest. 2000 Aug;106(3):329-33. Review. No abstract available. PMID: 10930434 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome.

    Cohen DP, Stein EM, Li Z, Matulis CK, Ehrmann DA, Layman LC.

    Fertil Steril. 1999 Aug;72(2):360-3.PMID: 10439012 [PubMed - indexed for MEDLINE]Related articles

    36.

    Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

    Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF 3rd, Spielman RS, Dunaif A.

    Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8573-8.PMID: 10411917 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Insulin-lowering therapeutic modalities for polycystic ovary syndrome.

    Ehrmann DA.

    Endocrinol Metab Clin North Am. 1999 Jun;28(2):423-38, viii. Review.PMID: 10352927 [PubMed - indexed for MEDLINE]Related articles

    38.

    Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

    Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J.

    Diabetes Care. 1999 Jan;22(1):141-6.PMID: 10333916 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Attenuation of hyperinsulinemia in polycystic ovary syndrome: what are the options?

    Ehrmann DA.

    J Endocrinol Invest. 1998 Oct;21(9):632-5. Review. No abstract available. PMID: 9856419 [PubMed - indexed for MEDLINE]Related articles

    40.

    Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.

    Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS.

    J Clin Invest. 1997 Aug 1;100(3):530-7.PMID: 9239399 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.

    Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS.

    J Clin Endocrinol Metab. 1997 Jul;82(7):2108-16.PMID: 9215280 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus.

    Ehrmann DA.

    Baillieres Clin Obstet Gynaecol. 1997 Jun;11(2):335-47. Review.PMID: 9536214 [PubMed - indexed for MEDLINE]Related articles

    43.

    Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor.

    Barnes RB, Ehrmann DA.

    J Clin Endocrinol Metab. 1997 Jun;82(6):1746-8. No abstract available. PMID: 9177374 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.

    Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS.

    J Clin Endocrinol Metab. 1997 Feb;82(2):524-30.PMID: 9024248 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study.

    Rosenfield RL, Perovic N, Ehrmann DA, Barnes RB.

    J Clin Endocrinol Metab. 1996 Sep;81(9):3408-11.PMID: 8784105 [PubMed - indexed for MEDLINE]Related articles

    46.

    The GENNID Study. A resource for mapping the genes that cause NIDDM.

    Raffel LJ, Robbins DC, Norris JM, Boerwinkle E, DeFronzo RA, Elbein SC, Fujimoto W, Hanis CL, Kahn SE, Permutt MA, Chiu KC, Cruz J, Ehrmann DA, Robertson RP, Rotter JI, Buse J.

    Diabetes Care. 1996 Aug;19(8):864-72.PMID: 8842605 [PubMed - indexed for MEDLINE]Related articles

    47.

    Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

    Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS.

    J Clin Invest. 1995 Jul;96(1):520-7.PMID: 7615824 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

    Ehrmann DA, Barnes RB, Rosenfield RL.

    Endocr Rev. 1995 Jun;16(3):322-53. Review. No abstract available. PMID: 7671850 [PubMed - indexed for MEDLINE]Related articles

    49.

    Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.

    Rosenfield RL, Barnes RB, Ehrmann DA.

    J Clin Endocrinol Metab. 1994 Dec;79(6):1686-92.PMID: 7989476 [PubMed - indexed for MEDLINE]Related articles

    50.

    Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.

    Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM.

    J Clin Endocrinol Metab. 1994 Nov;79(5):1328-33.PMID: 7962325 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...